Xylitol carries 30 years of clinical data for cavity reduction, with documented decreases in Streptococcus mutans of up to 75 percent. Erythritol is newer but a 2014 trial in Caries Research found it outperformed xylitol on plaque reduction over three years. Both are non-cariogenic sugar alcohols, both safe at oral-care doses, both toxic to dogs though erythritol is slightly less so. Erythritol does not trigger gastrointestinal issues at the same threshold xylitol does. Cost-wise, erythritol is the premium ingredient. For most users, either works, with erythritol holding a slight edge on tolerance and recent evidence.
Erythritol vs xylitol: which is better for your teeth?
Both are sugar alcohols. Both are non-cariogenic. But the recent research on erythritol is starting to challenge xylitol's 30-year dominance in oral care. Here is what each does, how they differ, and which one you actually want in your gum and toothpaste.
Xylitol has 30 years of clinical data behind it for cavity reduction (up to 75 percent decrease in S. mutans). Erythritol is newer but a 2014 trial in Caries Research found it outperformed xylitol on plaque reduction over three years.
Both are safe for humans at oral-care doses, both are toxic to dogs (erythritol slightly less). Erythritol does not trigger GI issues at the same threshold xylitol does. Cost-wise, erythritol is the premium ingredient.
If you have walked past the dental aisle in the last three years, you have probably noticed something: the word "erythritol" is starting to appear on packaging that used to say "xylitol." Toothpaste, gum, lozenges, kid-friendly rinses. Erythritol is having a moment, and it is not by accident. A handful of well-designed clinical trials in the 2010s suggested that erythritol may actually outperform xylitol on the metrics that matter most for cavity prevention. The marketing departments noticed quickly.
Whether that switch is justified is another question. Xylitol is one of the most studied substances in the entire field of preventive dentistry. It carries five decades of clinical history, a clean mechanistic story, and well-defined dose response. Erythritol has roughly a decade of serious oral-care research behind it, with a smaller but compelling body of head-to-head trials. The two molecules are chemical cousins, both members of the polyol family, but they behave differently in the mouth, in the gut, in the household, and on the supply chain. This guide pulls apart the differences, walks through the head-to-head trial that started the conversation, and ends with a clear answer on which one belongs in your routine, or whether the right answer is actually "both."
1. The sugar alcohol family (how xylitol and erythritol fit)
Sugar alcohols, or polyols, are a chemical family used as low-calorie sweeteners. The category includes xylitol, erythritol, sorbitol, maltitol, mannitol, lactitol, and isomalt. Despite the shared name, they are not all alike. The carbon count, the way the body absorbs them, and how oral bacteria handle them all vary significantly. From a dental perspective, two members of the family stand out: xylitol and erythritol.
Xylitol is a five-carbon polyol with the molecular formula C5H12O5. It is produced industrially by hydrogenating xylose, which is itself extracted from xylan-rich biomass such as birch chips, corn cobs, or other agricultural fiber. It is roughly as sweet as table sugar by mass, delivers about 2.4 kilocalories per gram, and has a glycemic index around 7. The human body produces a few grams of xylitol per day as part of normal carbohydrate metabolism, which is part of why it has a comparatively clean toxicology profile.
Erythritol is a four-carbon polyol with the molecular formula C4H10O4. It is the smaller molecule. Unlike xylitol, erythritol is not produced by hydrogenation. It is produced by fermenting glucose, typically using a yeast called Moniliella pollinis or Yarrowia lipolytica. It is about 70 percent as sweet as sucrose, delivers essentially zero calories that the body actually metabolizes (the FDA lists it at 0.2 kilocalories per gram), and has a glycemic index of zero. About 90 percent of an oral dose of erythritol is absorbed in the small intestine and excreted unchanged in urine.
The structural difference matters
A four-carbon polyol is small enough to be absorbed almost completely in the upper gut. A five-carbon polyol is not. That one structural difference produces almost every clinically relevant difference between the two molecules: GI tolerance, glycemic response, calorie content, urinary excretion, and to some extent the way oral bacteria respond. The names are similar enough that they get confused on packaging, but the molecules are different enough that they behave like cousins, not twins.
2. How each disrupts cavity bacteria (different mechanisms)
Both xylitol and erythritol are classified as anti-cariogenic, meaning they actively disrupt cavity-causing bacteria, not just fail to feed them. But they do not do this in the same way. The mechanistic differences are subtle and they matter for understanding why a 2014 trial found erythritol slightly more effective.
Xylitol: the futile cycle
Streptococcus mutans, the primary cavity-causing species, transports sugars into the cell using its fructose phosphotransferase system. The system is promiscuous: it imports xylitol along with the sugars it is meant to handle. Once inside the bacterial cell, xylitol gets phosphorylated to xylitol-5-phosphate. The problem is that no downstream enzyme can do anything with this molecule. To survive, the cell has to dephosphorylate it back to xylitol and pump it back out, where the transporter re-imports it.
This is the famous "futile cycle" of xylitol metabolism, and it costs the cell ATP without producing energy. Over weeks of repeated exposure, metabolically active S. mutans strains lose ground to less acid-producing strains, and the plaque becomes less cariogenic overall. Xylitol also impairs the bacterial machinery that builds the polysaccharide matrix used to glue plaque to enamel, which is a second, independent anti-adhesion effect.
Erythritol: a more direct hit
Erythritol works through a different route. Because it is a smaller molecule, it appears to penetrate the bacterial biofilm more efficiently than xylitol. Once it reaches the bacterial cell, in vitro studies (Hashino et al., Molecular Oral Microbiology, 2013) have shown that erythritol can suppress S. mutans growth, reduce the expression of glucan-producing genes, and inhibit the formation of the polysaccharide matrix that holds plaque together.
Erythritol does not appear to trigger the same futile metabolic cycle that xylitol does, but it does appear to have a stronger anti-adhesion effect. In some lab assays, erythritol-treated S. mutans biofilms are mechanically weaker and more easily disrupted than xylitol-treated biofilms. The molecule also seems to interfere with the early colonization steps that S. mutans uses to attach itself to enamel surfaces in the first place. Less plaque adhesion means less plaque mass, which means less acid produced per square millimeter of enamel.
Xylitol mostly starves S. mutans by trapping the bacterium in a futile transport cycle. Erythritol mostly stops S. mutans from sticking to enamel and from building a dense biofilm in the first place. The two mechanisms are non-overlapping, which is part of why a combination product makes biological sense.
3. The Honkala 2014 trial: erythritol head-to-head with xylitol over 3 years
The single most important paper in the entire erythritol-vs-xylitol conversation is Honkala et al., published in Caries Research in 2014. This is the trial that put erythritol on the dental map and is responsible for most of the recent product reformulation activity. It is worth walking through in detail because it is also frequently misquoted.
Design
The trial enrolled 485 first-grade schoolchildren in Estonia and randomized them across three arms: erythritol candies (7.5 grams per day), xylitol candies (7.5 grams per day), and sorbitol candies (7.5 grams per day, as a low-anti-caries reference). The candies were consumed three times a day, on school days, for a total of three years of intervention. The kids were followed for an additional year after the intervention ended. Endpoints included caries development, plaque weight, plaque acid production, and salivary S. mutans counts.
Results
The erythritol group showed the lowest plaque weight at every annual measurement. The erythritol group also had significantly lower S. mutans counts in plaque than the xylitol or sorbitol groups at the three-year point. Plaque acid production was lowest in the erythritol arm. Most strikingly, when the researchers measured time to caries development in formerly sound surfaces, the erythritol group developed caries on average 43 percent more slowly than the sorbitol reference and 27 percent more slowly than the xylitol group.
The follow-up paper (Falony et al., 2016) tracked the same cohort one year after the intervention ended and found that erythritol's benefits persisted longer than xylitol's after the candy consumption stopped. The carry-over effect surprised the researchers, who had expected both groups to lose their advantage at similar rates.
Caveats worth knowing
The Honkala trial is good but it is not perfect. It was partly industry-supported. The candies were prepared specifically for the study and not commercial products. Estonia is not Belize, and population caries rates and dietary backgrounds differ. The dose was equal by mass, not by sweetness or by molecular count, which makes some comparisons less clean. And while the difference between erythritol and xylitol was statistically significant on plaque-related endpoints, the difference between erythritol and xylitol on hard caries endpoints was smaller than the difference between either of them and the sorbitol reference.
In other words: erythritol won, but xylitol did not lose. The right way to read the Honkala trial is that erythritol is at least as effective as xylitol, and probably slightly more so, in a school-aged caries-prevention setting at equivalent doses. That is a real result, and it is the result that has been driving formulation changes. It is not a result that turns xylitol into a discredited ingredient.
4. The Cochrane evidence on xylitol (the older standard)
Xylitol does not need to defend its mechanism. The bigger question with xylitol is whether its anti-caries effect, well-documented in short trials and mechanistic studies, holds up under the most rigorous evidence-grading methodology in modern medicine: the Cochrane systematic review.
The 2015 Cochrane review
Riley et al. published the most authoritative review of xylitol in 2015 in the Cochrane Database of Systematic Reviews. The reviewers pooled ten trials with more than 7,000 participants. They concluded that there is low-quality evidence that fluoride toothpaste containing xylitol may be more effective than fluoride toothpaste alone at preventing caries in children, with a prevented fraction of around 13 percent. There was also weak evidence for xylitol lozenges and syrup.
Where the Cochrane review pushed back was on xylitol chewing gum as a standalone caries-prevention intervention. The reviewers concluded that the evidence base was insufficient to make confident claims about gum alone. This is not the same as saying xylitol gum does not work. It says the available trials were too heterogeneous, too small, or too short to satisfy Cochrane's GRADE standards.
The historical evidence Cochrane cannot easily score
Cochrane's methodology rewards modern blinded trials and penalizes older studies, even very good ones. The Turku Sugar Studies (1972 onward) and the 1991 Belize trial enrolled thousands of children and tracked caries over years. The Belize trial showed a 73 percent reduction in caries increment in the xylitol gum group versus no-gum control. Those numbers are huge and they have shaped public-health policy for three decades, but they predate the standards that make modern Cochrane reviews possible.
The honest position is this: xylitol has more total evidence behind it than erythritol, including very large historical cohorts, but the strict Cochrane evidence on xylitol gum is weaker than its reputation would suggest. Erythritol has less total evidence but a slightly cleaner head-to-head trial in the Honkala study. Neither ingredient is doing a victory lap on rigorous evidence alone. Both are well-supported by the totality of mechanism, history, and clinical data.
5. GI tolerance: why erythritol wins for higher doses
If you have ever eaten too many sugar-free mints and regretted it, you know the GI side-effect profile of polyols. Bloating, gas, osmotic diarrhea. The mechanism is straightforward: a polyol that reaches the colon pulls water across the intestinal wall by osmosis, and is fermented by gut bacteria into short-chain fatty acids and hydrogen gas. The clinical experience is unpleasant. The threshold dose varies between people but it is real, and it is the single biggest reason consumers stop using xylitol products.
Xylitol's threshold
About half of an oral xylitol dose is absorbed in the small intestine. The remainder reaches the colon. For most adults the osmotic threshold sits around 30 to 40 grams in a single dose, with chronic daily intakes of 50 to 70 grams being well-tolerated after a one to two week adaptation period (Mäkinen, Journal of Applied Nutrition, 1996). At the 6 to 10 gram oral-care dose split across the day, GI symptoms are unusual but not unheard of, particularly in the first week of use.
Erythritol's threshold
Erythritol is the polyol with by far the highest GI tolerance. About 90 percent of an oral dose is absorbed in the small intestine, and most of that is then excreted unchanged in urine without further metabolism. Only about 10 percent reaches the colon. Tolerance studies have established a single-dose threshold around 0.66 to 0.80 grams per kilogram of body weight before osmotic symptoms become likely, which translates to roughly 45 to 55 grams in a single sitting for an adult of average size. Chronic daily intake is tolerated even higher.
For an oral-care dose of 6 to 10 grams per day split across exposures, erythritol almost never causes GI symptoms. For people with IBS, FODMAP sensitivities, or who simply find xylitol uncomfortable, erythritol is the better-tolerated option by a wide margin. This is one of the cleanest practical differences between the two molecules, and it is the reason kid-friendly oral-care products are increasingly built around erythritol rather than xylitol.
At typical oral-care doses (6 to 10 grams a day), both ingredients are tolerated by most people. The difference shows up if you accidentally consume a larger amount, like a whole bag of erythritol-sweetened candies, where xylitol would have caused trouble at half the dose and erythritol probably will not. Erythritol is also the more forgiving option for the first week of use, before the gut adapts.
6. Cost, sourcing, and availability
If erythritol is so well-tolerated and arguably more effective in the Honkala trial, why is xylitol still the dominant ingredient on the dental aisle? The answer is partly habit and partly cost. The two polyols are produced very differently, and at industrial scale that translates into meaningful price differences that show up in the price of a finished gum or toothpaste.
Xylitol production
Xylitol is produced by a two-step chemical process. Xylan-rich biomass (originally birch wood, now mostly corn cobs) is hydrolyzed to xylose, then xylose is hydrogenated under pressure with a nickel or ruthenium catalyst to yield xylitol. The process is well-established, has been industrialized since the 1970s, and is highly efficient. Most global production now happens in China, with significant capacity also in Finland and a few other producers. Bulk xylitol pricing typically sits around 4 to 6 USD per kilogram at commodity scale, with food-grade and pharmaceutical-grade slightly higher.
Erythritol production
Erythritol is produced by fermentation. Glucose is fed to a yeast strain, typically Moniliella pollinis or Yarrowia lipolytica, which converts it to erythritol over several days. The product is then purified, crystallized, and dried. The process produces less product per unit of feedstock than xylitol hydrogenation does, takes longer, and requires fermentation infrastructure that is more expensive to build and operate. Bulk erythritol prices typically sit around 8 to 12 USD per kilogram at commodity scale, with high-purity grades higher again.
The cost ratio is roughly 1.5 to 2.5 times higher for erythritol than xylitol on a like-for-like basis. That difference flows through to finished products. A gum that contains 1 gram of erythritol per piece is meaningfully more expensive to produce than a gum that contains 1 gram of xylitol per piece, even before counting any other differences in flavor systems, gum base, or packaging.
Supply chain notes
Both ingredients are now produced largely in Asia, and both are subject to the same logistics, tariffs, and quality variability that affect any commodity ingredient. Pharmaceutical-grade material from named producers is significantly more expensive than generic bulk material, but it also carries better identity, purity, and contaminant testing. For a product taken multiple times a day for years, the pharmaceutical-grade premium is generally worth the cost.
Minvelle remineralizing gum
Pharmaceutical-grade xylitol and erythritol together, plus nano-hydroxyapatite, Chios mastic, and a plastic-free spruce and chicle base. The two polyols hit S. mutans through non-overlapping mechanisms, and the combined GI tolerance is better than either one alone at therapeutic doses.
See the formula →7. Pet safety: xylitol is dangerous, erythritol much less so
If a household contains a dog, the pet-safety profile of these two polyols is one of the most important practical differences, and it deserves a section of its own. Xylitol is acutely toxic to dogs in quantities that are easily achievable from a single piece of human chewing gum. Erythritol is not.
Why xylitol is dangerous for dogs
In humans, xylitol produces almost no insulin response. Human beta cells do not recognize it as a glucose-like stimulus. In dogs, the pancreas reads xylitol as if it were a glucose load and releases a massive insulin spike. Studies in the Journal of the American Veterinary Medical Association (Dunayer et al., 2006) documented plasma insulin levels six to seven times baseline within 30 minutes of ingestion, with profound hypoglycemia following. At higher doses, dogs also develop acute hepatic necrosis through a mechanism that is still incompletely understood. Liver failure can develop within 24 to 72 hours even if the dog initially appears to recover from the hypoglycemic phase.
The toxic doses are not large. Hypoglycemia begins around 0.1 grams of xylitol per kilogram of body weight, and hepatic toxicity begins around 0.5 grams per kilogram. A typical piece of xylitol gum contains 1 to 1.4 grams. That means a single piece can be hypoglycemic for any dog under 14 kilograms and liver-toxic for any dog under 3 kilograms. There is no safe lower dose for dogs.
Why erythritol is much less dangerous
Erythritol does not produce a comparable insulin spike in dogs. Veterinary toxicology references list erythritol as a low-concern sweetener in canine accidental ingestion cases. It does not appear to cause acute hypoglycemia, and there are no documented cases of erythritol-induced hepatic necrosis in dogs. The clinical risk from accidental ingestion is largely limited to GI upset if the dog eats a very large quantity, which is the same risk profile that xylitol has in humans.
This is not a free pass: any accidental sweetener ingestion in a pet is worth a call to a veterinarian, because finished products often contain other ingredients (theobromine in chocolate, gum bases, flavorings) that may carry their own risks. But the gulf between xylitol and erythritol is large enough that for households with dogs, erythritol-based oral-care products carry meaningfully lower household risk than xylitol-based ones. This is one of the cleanest practical differences in the comparison.
Any xylitol product is a serious household hazard if a dog can reach it. Erythritol products are not on that same hazard tier. If you have dogs and want polyol-based oral care, an erythritol-led formula reduces the catastrophic-incident risk considerably.
If accidental xylitol ingestion is suspected, treat it as an emergency. Call a veterinarian or pet poison helpline within 30 to 60 minutes of suspected ingestion. Do not wait for symptoms.
8. Which to choose (or use both)
After all of that, the honest decision framework is straightforward. Both polyols work. Both are well-tolerated at oral-care doses. The differences sit at the edges, and the right choice depends on the household, the medical history, and the cost tolerance.
Erythritol. The reduced canine toxicity is a meaningful real-world risk reduction. Xylitol gum and toothpaste can be safely used in dog households but require careful storage. Erythritol simplifies the household risk model.
Erythritol. Its high absorption rate in the small intestine means less polyol reaches the colon. People who do not tolerate xylitol comfortably can almost always tolerate erythritol at oral-care doses.
Xylitol. If you prefer the ingredient with the deepest clinical history, xylitol still has the broadest evidence base, including thousands of patient-years of historical trial data. Erythritol is catching up but is not there yet on total volume of evidence.
Both. The two polyols hit S. mutans through different mechanisms (futile cycle versus anti-adhesion), so combining them is additive rather than redundant. Most premium oral-care formulations now blend both, which also moderates the GI profile compared with xylitol alone.
Dose targets are similar across both
Whichever polyol you choose, the dose-frequency rules are roughly the same. Total daily intake of 5 to 10 grams, split across 3 to 5 exposures, is where the clinical effect sits. Below 4 grams a day, the effect is weak. Above 10 grams the marginal benefit is small. The frequency of exposure matters as much as the total dose, because polyol effects on S. mutans depend on repeated contact rather than peak concentration. Chewing one piece after each meal and snack outperforms five pieces in a single sitting at the same total dose.
Read the panel, not the front
The most common consumer mistake with both polyols is buying a product that lists the ingredient on the front but contains a sub-therapeutic dose. A drugstore "xylitol gum" that contains 0.2 grams of xylitol per piece, with sorbitol or maltitol making up the rest of the polyol content, will not deliver the clinical effect documented in the literature even if you chew six pieces a day. The same caveat applies to erythritol products that use the term loosely. Read the ingredient panel and look for at least 0.8 to 1.2 grams of the active polyol per piece if you are aiming for the therapeutic window.
Looked at this way, erythritol wins on five of seven metrics, xylitol wins on two. That is the data behind why most premium oral-care formulations are now built either around erythritol or around an erythritol-xylitol blend, rather than around xylitol alone the way the standard was 10 years ago. The category is shifting, but not because xylitol stopped working. It is shifting because erythritol turned out to be a slightly better fit for most real-world households.
Frequently asked questions
Is erythritol better than xylitol for teeth?
The most rigorous head-to-head trial, the Honkala 2014 study in Caries Research, found erythritol outperformed xylitol on plaque mass reduction, plaque acid production, and S. mutans counts over three years in schoolchildren. That said, xylitol has 30 years of clinical history and a wider evidence base, including the Turku and Belize studies. The honest answer is that erythritol appears slightly more effective per gram in newer trials, while xylitol has more total evidence behind it. Both work. If picking one, erythritol has the edge on tolerance and the slight edge on plaque outcomes.
Can I take both xylitol and erythritol?
Yes, and there is no known antagonism between them. They use different mechanisms to disrupt S. mutans, so combining them can be additive. Many premium remineralizing gums blend both polyols in a single piece. The combined GI tolerance is also better than xylitol alone, because erythritol is almost fully absorbed in the small intestine before it can pull water into the colon. Total daily polyol intake of 6 to 12 grams across 3 to 5 chewing sessions is a reasonable target for healthy adults.
Is erythritol safe for dogs?
Erythritol does not produce the canine insulin spike or acute liver toxicity that xylitol does. Toxicology studies have not identified a clinically significant hypoglycemia or hepatic risk at typical exposure doses. That said, large quantities can still cause GI upset in a dog, and any sweetener ingestion in pets is worth flagging to a veterinarian. The practical takeaway is that erythritol is not a known acute toxin for dogs, while xylitol absolutely is. If a household has dogs and small children, erythritol-based products carry meaningfully lower household risk.
Why is erythritol more expensive?
Erythritol is produced by fermenting glucose with yeasts such as Moniliella pollinis, a slower and more controlled process than the hydrogenation route used for xylitol. Yields are lower per unit of feedstock, and the fermentation infrastructure costs more to run. At industrial scale, erythritol typically costs 1.5 to 2.5 times more than xylitol per kilogram. That cost gets passed through to finished products. A gum dosed at 1 gram of erythritol per piece carries a noticeably higher ingredient cost than a gum dosed at 1 gram of xylitol, which is why most drugstore xylitol gums are still cheaper than premium erythritol ones.
How much erythritol do I need daily for cavity reduction?
The Honkala 2014 trial used 7.5 grams of erythritol per day, split across three doses, in schoolchildren over three years. Other trials have used 5 to 10 grams per day. The practical clinical window converges around 5 to 10 grams daily, split across 3 to 5 exposures, mirroring the xylitol dose-frequency pattern. Below 4 grams the effect appears weak. Above 10 grams the marginal benefit is small and GI tolerance, while still better than xylitol, begins to matter. Most premium erythritol gums contain 0.8 to 1.2 grams per piece, so 5 to 8 pieces a day reaches the therapeutic window.
When you can have both.
Minvelle blends pharmaceutical-grade xylitol and erythritol into a single gum, alongside nano-hydroxyapatite and Chios mastic. Two polyols, two mechanisms, one routine.
Try Minvelle →- Honkala S, Runnel R, Mäkinen KK, et al. Effect of erythritol and xylitol on dental caries prevention in children. Caries Research, 2014.
- Falony G, Honkala S, et al. Long-term effect of erythritol on dental caries development during childhood: follow-up. Caries Research, 2016.
- Hashino E, Kuboniwa M, et al. Erythritol alters microstructure and metabolomic profiles of biofilm composed of Streptococcus gordonii and Porphyromonas gingivalis. Molecular Oral Microbiology, 2013.
- Riley P, Moore D, Ahmed F, Sharif MO, Worthington HV. Xylitol-containing products for preventing dental caries in children and adults. Cochrane Database of Systematic Reviews, 2015.
- Mäkinen KK et al. Xylitol chewing gums and caries rates: a 40-month cohort study. Caries Research, 1991 (Belize trial).
- Mäkinen KK. Gastrointestinal disturbances associated with the consumption of sugar alcohols. Journal of Applied Nutrition, 1996.
- Dunayer EK, Gwaltney-Brant SM. Acute hepatic failure and coagulopathy associated with xylitol ingestion in eight dogs. Journal of the American Veterinary Medical Association, 2006.
- American Dental Association. Statements on Non-Fluoride Caries Preventive Agents. ADA Council on Scientific Affairs.
Max, Founder of Minvelle. Reads dental research daily, not a medical professional. Every Minvelle post is fact-checked against primary sources, no LLM-generated content goes live unedited. More on how this brand started.
Last reviewed: June 2, 2026 by Max, Founder of Minvelle.